A Comparative Study to Assess the Mental Health Problems, Quality of Life, Work Ability and Social Adjustments Among OST and Non-OST Drug Users in Chandigarh
-
Published:2022-10
Issue:4
Volume:18
Page:191-204
-
ISSN:0974-150X
-
Container-title:Nursing & Midwifery Research Journal
-
language:en
-
Short-container-title:Nursing & Midwifery Research Journal
Author:
Kumar Pardeep1, Sharma Sunita2, Saini Sushma Kumari3, Mittal Sandeep4, Gupta Vanita5
Affiliation:
1. Nursing Officer, Postgraduate Institute of Medical Education and Research, Chandigarh, India 2. Associate Professor, National Institute of Nursing Education, Postgraduate Institute of Medical Education and Research, Chandigarh, India 3. Associate Professor, National Institute of Nursing Education, Postgraduate Institute of Medical Education and Research, Chandigarh, India. 4. Deputy Director, State AIDS, Control Society, Chandigarh, India 5. Director, State AIDS, Control Society, Chandigarh, India
Abstract
Introduction: Injectable drug use is a cause of disease burden and a contributor to blood-borne virus transmission and health-related problems. It is one of the serious problems of our country. The best suitable strategy of treatment for opioid dependence is ‘opioid substitution therapy’ (OST). It is beneficial for the injectable drug users (IDUs) in reduction in the behaviour of injecting and opioid use, which helps in reducing criminal activities, domestic violence, enhancing ties within the family and improving productivity. Objective: To assess the mental health problems, quality of life, work ability and social adjustability among OST and non-OST IDUs. Materials and Methods: The descriptive study was conducted among 100 male IDUs (50 in the OST group and 50 in the non-OST group), registered with the two selected non-governmental organizations (NGOs) of Chandigarh selected by using the consecutive sampling technique. The OST group was contacted during their visit to the centre for receiving the daily dose of OST, while the non-OST group was contacted during their visit to the NGO centres for getting fresh syringes in exchange with used syringes under the syringe exchange programme. The data were collected by interviewing the study subjects by using the interview schedule comprising of the (a) socio-demographic profile, (b) health problems, (c) substance-use-related problems scale, (d) work ability and social adjustability scale, (e) the depression, anxiety and stress scale-21 and (f) World Health Organization Quality-of-Life BREF (WHOQOL BREF) Scale. All the tools were standardized and available in the open domain. Results: The study subjects were in the age group of 18–58 years with the mean age of 27.52 ± 6.67 years. Significantly lesser problems in the OST group study participants related to health, occupation, finance, legal, family, marital and social status were reported than those in the non-OST group participants ( t-test, p < 0.01). A significantly higher percentage of the study participants in the non-OST group had depression, anxiety and stress than that in the OST group. Quality of life of IDUs in the OST group was significantly better than that of IDUs in the non-OST group, as per the WHOQOL BREF Scale (Mann–Whitney U test, p < 0.05). Conclusion: IDUs on OST therapy (OST group) were having lesser problems in the area of health (physical and mental), occupational, financial, legal, family, marital, social and better quality of life than those in the non-OST group.
Publisher
SAGE Publications
Subject
Education,Cultural Studies
Reference17 articles.
1. World Health Organization, International Narcotics Control Board, United Nations Office on Drugs and Crime, editors. Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence. Geneva: World Health Organization, https://www.who.int/substance_abuse/publications/Opioid_dependence_guidelines.pdf (2009, accessed 24 January 2019). 2. United Nations Office on Drugs and Crime. National survey on extent, pattern and trends of drug abuse in India. New Delhi: Ministry of Social Justice and Empowerment, Government of India, and United Nations Office on Drugs and Crime, https://www.unodc.org/pdf/india/presentations/india_national_survey_2004.pdf (2004, accessed 20 March 2019). 3. Ambekar A, and Goyal S. Clinical practice guidelines (CPG) for the management of opioid use disorders, http://www.indianjpsychiatry.org/documents/IPSCPGSUDSynopsisBook2015.pdf (accessed 24 January 2019). 4. Treatment, rehabilitation and social reintegration for drug use disorders: essential components of drug demand reduction 5. Kumar MS, Samson L, Momenghalibaf A et al. Advocacy brief: Pharmaceutical injection drug use in South Asia. New Delhi: Indian Harm Reduction Network, Response Beyond Borders and Sharan, http://naco.gov.in/sites/default/files/Opiod%20Substitution%20Therapy%20Guideline.pdf (accessed 15 January 2019).
|
|